QuintilesIMS Institute Report: PBM Tools Increase Competition, Curb Drug Spending

QuintilesIMS Institute Report: PBM Tools Increase Competition, Curb Drug Spending

A new IMS Institute report found that discounts, rebates, and other price concessions negotiated by PBMs on brand drugs reduced spending by an estimated 28% to $323.1 billion last year, and average patient out-of-pocket costs declined from $9.66 in 2013 to $8.47 in 2016.